| The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis C Therkildsen, TK Bergmann, T Henrichsen-Schnack, S Ladelund, ... Acta oncologica 53 (7), 852-864, 2014 | 449 | 2014 |
| BCPT policy for experimental and clinical studies P Tveden-Nyborg, TK Bergmann, N Jessen, U Simonsen, J Lykkesfeldt Basic & clinical pharmacology & toxicology 128 (1), 4-8, 2021 | 294 | 2021 |
| Basic & clinical pharmacology & toxicology policy for experimental and clinical studies P Tveden-Nyborg, TK Bergmann, J Lykkesfeldt Basic & clinical pharmacology & toxicology 123 (3), 233-235, 2018 | 288 | 2018 |
| Clinical pharmacokinetics of paclitaxel monotherapy: an updated literature review TB Stage, TK Bergmann, DL Kroetz Clinical pharmacokinetics 57 (1), 7-19, 2018 | 163 | 2018 |
| Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation TK Bergmann, KA Barraclough, KJ Lee, CE Staatz Clinical pharmacokinetics 51, 711-741, 2012 | 148 | 2012 |
| Impact of CYP2C8* 3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer TK Bergmann, C Brasch-Andersen, H Green, M Mirza, RS Pedersen, ... The pharmacogenomics journal 11 (2), 113-120, 2011 | 126 | 2011 |
| Linkage disequilibrium between the CYP2C19*17 allele and wildtype CYP2C8 and CYP2C9 alleles: identification of CYP2C haplotypes in healthy Nordic … RS Pedersen, C Brasch-Andersen, SC Sim, TK Bergmann, J Halling, ... European journal of clinical pharmacology 66, 1199-1205, 2010 | 110 | 2010 |
| Retrospective study of the impact of pharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancer TK Bergmann, H Gréen, C Brasch-Andersen, MR Mirza, J Herrstedt, ... European journal of clinical pharmacology 67, 693-700, 2011 | 102 | 2011 |
| Population Pharmacokinetics of Tacrolimus in Adult Kidney Transplant Patients: Impact of: CYP3A5: Genotype on Starting Dose TK Bergmann, S Hennig, KA Barraclough, NM Isbel, CE Staatz Therapeutic drug monitoring 36 (1), 62-70, 2014 | 93 | 2014 |
| Improved prediction of tacrolimus concentrations early after kidney transplantation using theory‐based pharmacokinetic modelling E Størset, N Holford, S Hennig, TK Bergmann, S Bergan, S Bremer, ... British journal of clinical pharmacology 78 (3), 509-523, 2014 | 80 | 2014 |
| NR1I2 polymorphisms are related to tacrolimus dose-adjusted exposure and BK viremia in adult kidney transplantation KA Barraclough, NM Isbel, KJ Lee, TK Bergmann, DW Johnson, ... Transplantation 94 (10), 1025-1032, 2012 | 60 | 2012 |
| Impact of ABCB1 Variants on Neutrophil Depression: A Pharmacogenomic Study of Paclitaxel in 92 Women with Ovarian Cancer TK Bergmann, C Brasch‐Andersen, H Gréen, MR Mirza, K Skougaard, ... Basic & clinical pharmacology & toxicology 110 (2), 199-204, 2012 | 54 | 2012 |
| Docetaxel-induced neuropathy: a pharmacogenetic case-control study of 150 women with early-stage breast cancer L Eckhoff, S Feddersen, AS Knoop, M Ewertz, TK Bergmann Acta Oncologica 54 (4), 535-542, 2015 | 52 | 2015 |
| Multiple Hepatic Abscesses Due to Yersinia enterocolitica Infection Secondary to Primary Haemochromatosis TK Bergmann, K Vinding, H Hey Scandinavian journal of gastroenterology 36 (8), 891-895, 2001 | 52 | 2001 |
| BCPT 2023 policy for experimental and clinical studies P Tveden-Nyborg, TK Bergmann, N Jessen, U Simonsen, J Lykkesfeldt Basic & clinical pharmacology & toxicology 133 (4), 391-396, 2023 | 47 | 2023 |
| Key learning outcomes for clinical pharmacology and therapeutics education in Europe: a modified Delphi study DJ Brinkman, J Tichelaar, LB Mokkink, T Christiaens, R Likic, ... Clinical Pharmacology & Therapeutics 104 (2), 317-325, 2018 | 47 | 2018 |
| A cancer that went up in smoke: pulmonary reaction to e-cigarettes imitating metastatic cancer LR Madsen, NHV Krarup, TK Bergmann, S Bærentzen, S Neghabat, ... Chest 149 (3), e65-e67, 2016 | 47 | 2016 |
| Duplication of CYP2D6 predicts high clearance of desipramine but high clearance does not predict duplication of CYP2D6 T Bergmann, L Bathum, K Brosen European journal of clinical pharmacology 57, 123-127, 2001 | 40 | 2001 |
| GWAS-based association between RWDD3 and TECTA variants and paclitaxel induced neuropathy could not be confirmed in Scandinavian ovarian cancer patients TK Bergmann, W Vach, S Feddersen, L Eckhoff, H Gréen, J Herrstedt, ... Acta Oncologica 52 (4), 871-873, 2013 | 32 | 2013 |
| Clopidogrel–Paclitaxel Drug–Drug Interaction: A Pharmacoepidemiologic Study K Agergaard, M Mau‐Sørensen, TB Stage, TL Jørgensen, RE Hassel, ... Clinical Pharmacology & Therapeutics 102 (3), 547-553, 2017 | 29 | 2017 |
Kim BrøsenProfessor in Clinical Pharmacology, University of Southern DenmarkVerified email at health.sdu.dk
